Tectonic Therapeutic, Inc. (TECX) stock

TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30

$21.96−0.01 (-0.05%)

Close on Nov 11, 2026Market cap $429.30MP/E –Yield 0.00%

Tectonic Therapeutic gross margin

Gross margin is gross profit as a percentage of revenue.

Tectonic Therapeutic has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?